In glioma, miR-15a/16 depletion activated tumor-infiltrating CD8+ T cells via the mammalian target of rapamycin (mTOR) signaling pathway, as indicated by the downregulation of PD-1 expression and the increase of the anti-tumor factor IFN-γ production in T cells (114). The gene discussed is MTOR; the disease is central nervous system cancer.